Ping Yan

3.8k citations
58 papers · 2.9k · 3 hit papers · h-index 24

Impact in

Papers in

Ping Yan

56 papers receiving 2.8k citations

Ping Yan's Hit Papers

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial 2021 · 193 citations
1930+5+10Years since publication100200300400500

Peers

Ping Yan
Comparison fields: 5 of 122
  • Endocrinology, Diabetes and Metabolism 1.2k
  • Nephrology 216
  • Hepatology 151
  • Pharmacology 229
  • Spectroscopy 214
Replace Masafumi Koga with:
Masafumi Koga Japan
Hideaki Jinnouchi Japan
Frank Dellanna Germany
Takuma Narita Japan
Kathryn Jean Lucas United States
Alistair M Emslie-Smith United Kingdom
Oleksandr Larin Russia
Peter Santer Austria
Laura M. Yerges‐Armstrong United States
Jennifer E. Sugg United States
Ping Yan relative to Masafumi Koga Japan Masafumi Koga's profile →
Citations per field
00.5×5×10×14.3×
Masafumi Koga · 1×
Citations per year

Countries citing papers authored by Ping Yan

Since Specialization
Citations

This map shows the geographic impact of Ping Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Yan more than expected).

Fields of papers citing papers by Ping Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Yan. The network helps show where Ping Yan may publish in the future.

Co-authors

The 25 scholars most cited alongside Ping Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ping Yan Line = papers co-authored together Ping Yan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
Hit paper breakdown →
2010528
2
DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes
Hit paper breakdown →
2011390
3
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Hit paper breakdown →
2021193
4 2014184
5 2014158
6 2010122
7 2021122
8 2010120
9 2020115
10 2011103
11 202069
12 201458
13 201250
14 201149
15 202146
16 202045
17 201941
18 201038
19 201634
20 202333

About Ping Yan

Ping Yan is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Oncology and Critical Care and Intensive Care Medicine, having authored 58 papers that have together received 2.9k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (19 papers), Diabetes Treatment and Management (8 papers), Chronic Kidney Disease and Diabetes (5 papers), Dialysis and Renal Disease Management (5 papers), Sepsis Diagnosis and Treatment (5 papers), Advanced Proteomics Techniques and Applications (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Cardiovascular Health and Disease Prevention (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Nephrology (216 citations), Hepatology (151 citations), Pharmacology (229 citations) and Spectroscopy (214 citations). Ping Yan has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jaret L. Malloy, Brandon Walsh, Richard M. Bergenstal, Carol Wysham, Leigh MacConell, Lisa E. Porter, Ken Wilhelm, Lisa Ann Porter, John R. Pullman and Christine T. Schulteis. Their work appears in journals such as Scientific Reports, European Radiology, Renal Failure, Annals of Oncology and Oxidative Medicine and Cellular Longevity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact